HALO reports Thursday, Nov 5, 2026, after the close. After the last 4 reports the stock moved +20.2%, +6.8%, −9.0%, +2.8% the next day.
HALO is expected to report on Thursday, Nov 5, 2026, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Aug 6, 2026 | 1.82 | 2.28 | +20.2% | +17.4% |
| May 11, 2026 | 1.52 | 1.60 | +6.8% | +1.6% |
| Feb 17, 2026 | 2.20 | -0.24 | −9.0% | −12.6% |
| Nov 3, 2025 | 1.63 | 1.72 | +2.8% | +2.7% |
| Aug 5, 2025 | 1.27 | 1.54 | +2.5% | +5.3% |
| May 6, 2025 | 0.95 | 1.11 | +18.1% | −15.4% |
| Feb 18, 2025 | 1.16 | 1.26 | −0.2% | +0.2% |
| Oct 31, 2024 | 1.00 | 1.27 | +13.0% | +18.0% |
Average move the next trading day over the last 8 reports: ±9.1% (6 of 8 up).
HALO is in an uptrend, momentum firm. $131.18 is the level overhead; $125 the first support below.
HALO at $128.62. Nearest resistance $131.18 (+2.0%). Nearest support $125.00 (−2.8%).
HALO chart, levels and analysis · Latest analysis: Halozyme Therapeutics (HALO) stock analysis, October 28, 2026: Parabolic uptrend leads market, but stretched into earnings · Earnings this week
HALO is expected to report on Thursday, Nov 5, 2026, after the close.
HALO reports after the close, US Eastern time.
After its report on Aug 6, 2026, HALO moved +20.2% the next trading day.
Over the last 8 reports, HALO moved 9.1% on average the next trading day, up 6 times out of 8.